In addition to depleting CD8+ T cells, suppressing the dysfunction of CD8+ T cells in the liver may also be an effective way to alleviate liver damage induced by NAFLD. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.